Lv11
58 积分 2022-08-13 加入
Comprehensive resistance profiling of chronic myeloid leukaemia associated ABL1 variants against five tyrosine kinase inhibitors using prime editing
29天前
已完结
[Clonal hematopoiesis in aplastic anemia and paroxysmal nocturnal hemoglobinuria]
3个月前
已完结
Paroxysmal nocturnal hemoglobinuria and myelodysplastic syndrome: Disappearance of cytogenetic abnormalities
3个月前
已完结
Real-World Prevalence and Outcomes of Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with C5 Inhibitors in the US: A Retrospective Claims Database Analysis
3个月前
已完结
Genomic profiling for decision-making in post-polycythemia vera and post-essential thrombocythemia myelofibrosis
4个月前
已关闭
MUTATIONAL STATUS AND TREATMENT EFFICACY IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA
5个月前
已关闭
Risk factors for left atrial thrombus or spontaneous echo contrast in non-valvular atrial fibrillation patients with low CHA2DS2-VASc score
5个月前
已完结
Future directions in myelodysplastic syndromes/neoplasms and acute myeloid leukaemia classification: from blast counts to biology
9个月前
已完结
Myelodysplastic syndromes versus acute myeloid leukaemia: biology or blasts—what truly defines the disease and does it matter?
9个月前
已关闭
[How do aldosterone blockers associated with ACE inhibitors or ARBs affect proteinuria in patients with chronic kidney disease?]
9个月前
已关闭
皖公网安备34019202002308
